Lysergic acid diethylamide is under clinical development by Mind Medicine MindMed and currently in Phase II for Major Depressive Disorder.

The most-read articles addressing mental health in 2024 spanned therapeutic advancements, research discoveries, and insight ...

In past trials, ketamine intravenous treatment has shown promise, with 64% of depression patients in trials experiencing ...

For others, they may need more treatment. Overall, the program has had high response rates among Ascension patients. TMS is insurance covered but providers will likely require step therapy as the ...

CMS has balked at covering vagus nerve stimulation for treatment-resistant depression. Positive results from an ...

In a recent study, transcranial magnetic stimulation was found to be more effective than switching to a new medication for ...

At 14, she says that she was aware of eating disorders ... treatment centers trying to recover from the eating disorder. "It's just taken my life away pretty much," she reflects. Asked why ...

a licensed mental health professional can give you a proper diagnosis and help you find a treatment that works for you. The symptoms of bipolar disorder include depression, mania, and hypomania.

While antidepressants are widely used to treat mood and anxiety disorders, only half of the patients will respond to antidepressant treatment ... prescribed to treat depression and anxiety ...

These approaches may be incorporated separately or in combination with dietary changes, depending on your symptoms and treatment ... depression symptoms. Healthline has strict sourcing guidelines ...

The equipment costs about £250,000 but it could save money, given staff shortages in histopathology and the likelihood of less need for further treatment. John Elliot, the trust's head of cancer ...